Soluble CD146 in cerebrospinal fluid of active multiple sclerosis

Neuroscience

Volumn 235, Issue , 2013, Pages 16-26

  Duan, H ^a,b   Luo, Y ^a   Hao, H ^c   Feng, L ^d   Zhang, Y ^a   Lu, D ^a   Xing, S ^a,b   Feng, J ^a   Yang, D ^a   Song, L ^a   Yan, X ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cerebrospinal fluid; Inflammatory factors; Multiple sclerosis; SCD146

Indexed keywords

CD146 ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 2; MYELIN BASIC PROTEIN ANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LEUKOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; REMISSION; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIGENS, CD146; BIOLOGICAL MARKERS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CELL MIGRATION ASSAYS, LEUKOCYTE; CYTOKINES; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; INTERCELLULAR ADHESION MOLECULE-1; ISOELECTRIC FOCUSING; MALE; MEMBRANES; MULTIPLE SCLEROSIS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84873717470     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.01.020     Document Type: Article

References (50)

1. Acar G., Idiman F., Kirkali G., Ozakbas S., Oktay G., Cakmakci H., Idiman E. Intrathecal sICAM-1 production in multiple sclerosis-correlation with triple dose Gd-DTPA MRI enhancement and IgG index. J Neurol 2005, 252:146-150.
2. Alves-Leon S.V., Batista E., Papais-Alvarenga R., Quirico-Santos T. Determination of soluble ICAM-1 and TNFalphaR in the cerebrospinal fluid and serum levels in a population of Brazilian patients with relapsing-remitting multiple sclerosis. Arq Neuropsiquiatr 2001, 59:18-22.
3. Awad A., Hemmer B., Hartung H.P., Kieseier B., Bennett J.L., Stuve O. Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis. J Neuroimmunol 2010, 219:1-7.
4. Bahbouhi B., Berthelot L., Pettre S., Michel L., Wiertlewski S., Weksler B., Romero I.A., Miller F., Couraud P.O., Brouard S., Laplaud D.A., Soulillou J.P. Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line. J Leukoc Biol 2009, 86:1049-1063.
5. Baraczka K., Pozsonyi T., Nekam K., Viranyi M., Sesztak M., Szongoth M., Jakab L. Soluble L-selectin levels in serum and cerebrospinal fluid in patients with multiple sclerosis and systemic lupus erythematosus. Acta Neurol Scand 2000, 102:114-117.
6. Baraczka K., Nekam K., Pozsonyi T., Jakab L., Szongoth M., Sesztak M. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement. Neuroimmunomodulation 2001, 9:49-54.
7. Bardin N., Frances V., Combes V., Sampol J., Dignat-George F. CD146: biosynthesis and production of a soluble form in human cultured endothelial cells. FEBS letters 1998, 421:12-14.
8. Bardin N., Anfosso F., Masse J.M., Cramer E., Sabatier F., Le Bivic A., Sampol J., Dignat-George F. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 2001, 98:3677-3684.
9. Bardin N., Moal V., Anfosso F., Daniel L., Brunet P., Sampol J., Dignat George F. Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration. Thrombosis and haemostasis 2003, 90:915-920.
10. Bardin N., Reumaux D., Geboes K., Colombel J.F., Blot-Chabaud M., Sampol J., Duthilleul P., Dignat-George F. Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflammatory bowel diseases 2006, 12:16-21.
11. Bardin N., Blot-Chabaud M., Despoix N., Kebir A., Harhouri K., Arsanto J.P., Espinosa L., Perrin P., Robert S., Vely F., Sabatier F., Le Bivic A., Kaplanski G., Sampol J., Dignat-George F. CD146 and its soluble form regulate monocyte transendothelial migration. Arterioscler Thromb Vasc Biol 2009, 29:746-753.
12. Boneberg E.M., Illges H., Legler D.F., Furstenberger G. Soluble CD146 is generated by ectodomain shedding of membrane CD146 in a calcium-induced, matrix metalloprotease-dependent process. Microvasc Res 2009, 78:325-331.
13. Colombo E., Borgiani B., Verderio C., Furlan R. Microvesicles: novel biomarkers for neurological disorders. Front Physiol 2012, 3:63.
14. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
15. Correale J., Bassani Molinas Mde L. Temporal variations of adhesion molecules and matrix metalloproteinases in the course of MS. J Neuroimmunol 2003, 140:198-209.
16. Figarella-Branger D., Schleinitz N., Boutiere-Albanese B., Camoin L., Bardin N., Guis S., Pouget J., Cognet C., Pellissier J.F., Dignat-George F. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies. J Rheumatol 2006, 33:1623-1630.
17. Filippi M. Multiple sclerosis in 2010: Advances in monitoring and treatment of multiple sclerosis. Nat Rev Neurol 2011, 7:74-75.
18. Frisullo G., Nociti V., Iorio R., Patanella A.K., Marti A., Caggiula M., Mirabella M., Tonali P.A., Batocchi A.P. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. Cytokine 2008, 44:22-25.
19. Guezguez B., Vigneron P., Lamerant N., Kieda C., Jaffredo T., Dunon D. Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor. J Immunol 2007, 179:6673-6685.
20. Harhouri K., Kebir A., Guillet B., Foucault-Bertaud A., Voytenko S., Piercecchi-Marti M.D., Berenguer C., Lamy E., Vely F., Pisano P., Ouafik L., Sabatier F., Sampol J., Bardin N., Dignat-George F., Blot-Chabaud M. Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia. Blood 2010, 115:3843-3851.
21. Hu W., Lucchinetti C.F. The pathological spectrum of CNS inflammatory demyelinating diseases. Semin Immunopathol 2009, 31:439-453.
22. Ishizu T., Osoegawa M., Mei F.J., Kikuchi H., Tanaka M., Takakura Y., Minohara M., Murai H., Mihara F., Taniwaki T., Kira J. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005, 128:988-1002.
23. Jeanneteau J., Hibert P., Martinez M.C., Tual-Chalot S., Tamareille S., Furber A., Andriantsitohaina R., Prunier F. Microparticle release in remote ischemic conditioning mechanism. Am J Physiol Heart Circ Physiol 2012, 303:H871-877.
24. Jilek S., Schluep M., Rossetti A.O., Guignard L., Le Goff G., Pantaleo G., Du Pasquier R.A. CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis. Clin Immunol 2007, 123:105-113.
25. Jimenez J., Jy W., Mauro L.M., Horstman L.L., Ahn E.R., Ahn Y.S., Minagar A. Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes. Mult Scler 2005, 11:310-315.
26. Kaspi E, Guillet B, Piercecchi-Marti MD, Alfaidy N, Bretelle F, Bertaud-Foucault A, Stalin J, Rambeloson L, Lacroix O, Blot-Chabaud M, Dignat-George F, Bardin N (2012) Identification of soluble CD146 as a regulator of trophoblast migration: potential role in placental vascular development. Angiogenesis [Epub ahead of Print].
27. Kikuchi S., Fukazawa T., Niino M., Yabe I., Miyagishi R., Hamada T., Hashimoto S.A., Tashiro K. HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen. Neurology 2003, 60:647-651.
28. Kuenz B., Lutterotti A., Khalil M., Ehling R., Gneiss C., Deisenhammer F., Reindl M., Berger T. Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis. J Neuroimmunol 2005, 167:143-149.
29. Larochelle C., Cayrol R., Kebir H., Alvarez J.I., Lecuyer M.A., Ifergan I., Viel E., Bourbonniere L., Beauseigle D., Terouz S., Hachehouche L., Gendron S., Poirier J., Jobin C., Duquette P., Flanagan K., Yednock T., Arbour N., Prat A. Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system. Brain 2012, 135:2906-2924.
30. Malyszko J., Malyszko J.S., Brzosko S., Wolczynski S., Mysliwiec M. Markers of endothelial cell activation/injury: CD146 and thrombomodulin are related to adiponectin in kidney allograft recipients. Am J Nephrol 2005, 25:203-210.
31. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127.
32. McDonnell G.V., McMillan S.A., Douglas J.P., Droogan A.G., Hawkins S.A. Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease. J Neurol 1999, 246:87-92.
33. McMillan S.A., McDonnell G.V., Douglas J.P., Hawkins S.A. Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis. Acta Neurol Scand 2000, 101:239-243.
34. Michalowska-Wender G., Losy J., Wender M. Biological markers to confirm diagnosis and monitor the therapy in multiple sclerosis patients. Folia Neuropathol 2001, 39:1-5.
35. Minagar A., Jy W., Jimenez J.J., Sheremata W.A., Mauro L.M., Mao W.W., Horstman L.L., Ahn Y.S. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001, 56:1319-1324.
36. Neidhart M., Wehrli R., Bruhlmann P., Michel B.A., Gay R.E., Gay S. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis. Arthritis and rheumatism 1999, 42:622-630.
37. Ransohoff R.M. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J Neuroimmunol 1999, 98:57-68.
38. Reumaux D., Bardin N., Colombel J.F., Dignat-George F., Duthilleul P., Vermeire S. Restoration of soluble CD146 in patients with Crohn's disease treated with the TNF-alpha antagonist infliximab. Inflammatory bowel diseases 2007, 13:1315-1317.
39. Rieckmann P., Altenhofen B., Riegel A., Baudewig J., Felgenhauer K. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis. Ann Neurol 1997, 41:326-333.
40. Saito T., Saito O., Kawano T., Tamemoto H., Kusano E., Kawakami M., Ishikawa S.E. Elevation of serum adiponectin and CD146 levels in diabetic nephropathy. Diabetes Res Clin Pract 2007, 78:85-92.
41. Sanborn M.R., Thom S.R., Bohman L.E., Stein S.C., Levine J.M., Milovanova T., Maloney-Wilensky E., Frangos S., Kumar M.A. Temporal dynamics of microparticle elevation following subarachnoid hemorrhage. J Neurosurg 2012, 117:579-586.
42. Spuler S., Yousry T., Scheller A., Voltz R., Holler E., Hartmann M., Wick M., Hohlfeld R. Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity. J Neuroimmunol 1996, 66:57-64.
43. St Croix B., Rago C., Velculescu V., Traverso G., Romans K.E., Montgomery E., Lal A., Riggins G.J., Lengauer C., Vogelstein B., Kinzler K.W. Genes expressed in human tumor endothelium. Science (New York. NY 2000, 289:1197-1202.
44. Tsiolakidou G., Koutroubakis I.E., Tzardi M., Kouroumalis E.A. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Dig Liver Dis 2008, 40:673-679.
45. Weksler B.B., Subileau E.A., Perriere N., Charneau P., Holloway K., Leveque M., Tricoire-Leignel H., Nicotra A., Bourdoulous S., Turowski P., Male D.K., Roux F., Greenwood J., Romero I.A., Couraud P.O. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005, 19:1872-1874.
46. Weller R.O., Engelhardt B., Phillips M.J. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol 1996, 6:275-288.
47. Yan X., Lin Y., Yang D., Shen Y., Yuan M., Zhang Z., Li P., Xia H., Li L., Luo D., Liu Q., Mann K., Bader B.L. A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood 2003, 102:184-191.
48. Zhang Y., Zheng C., Zhang J., Yang D., Feng J., Lu D., Yan X. Generation and characterization of a panel of monoclonal antibodies against distinct epitopes of human CD146. Hybridoma (Larchmt) 2008, 27:345-352.
49. Zhang B.R., Li L., Feng L.Q., Zhang Y., Zeng X.F., Feng J., Yang D.L., Zheng C.G., Yan X.Y. Elevated Levels of Soluble and Neutrophil CD146 in Active Systemic Vasculitis. Labmedicine 2009, 40:351-356.
50. Zheng C., Qiu Y., Zeng Q., Zhang Y., Lu D., Yang D., Feng J., Yan X. Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization. Int J Biochem Cell Biol 2009, 41:2163-2172.